Drug · DIN 02493977
LENALIDOMIDE
No: cancelled before it was sold
Authorized, then cancelled before it was ever sold in Canada.
Status Cancelled Pre Market since November 16, 2022.
- Drug Identification Number (DIN)
- 02493977
- Company (DIN owner)
- Natco Pharma (Canada) IncMississauga, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Capsule
- Route
- Oral
- Therapeutic class (ATC)
- Lenalidomide L04AX04
- Class
- Human
- Record last updated
- July 20, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| LENALIDOMIDE | 20 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- September 1, 2021: NOC 26559Abbreviated New Drug Submission (ANDS)
Other DINs named LENALIDOMIDE
- DIN 02493926 · Cancelled Pre Market
- DIN 02493934 · Cancelled Pre Market
- DIN 02493942 · Cancelled Pre Market
- DIN 02493950 · Cancelled Pre Market
- DIN 02493969 · Cancelled Pre Market
- DIN 02493985 · Cancelled Pre Market